Unethical use of imiquimod as a comparator group in a randomized clinical trial of children with molluscum contagiosum

J Am Acad Dermatol. 2021 Feb;84(2):e113. doi: 10.1016/j.jaad.2020.09.095. Epub 2020 Oct 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Aminoquinolines / therapeutic use
  • Child
  • Humans
  • Imiquimod
  • Molluscum Contagiosum* / drug therapy

Substances

  • Adjuvants, Immunologic
  • Aminoquinolines
  • Imiquimod